Literature DB >> 500133

Complement activation by aluminium and zirconium compounds.

V D Ramanathan, P Badenoch-Jones, J L Turk.   

Abstract

The activation of complement by a number of metal compounds, previously found to induce chronic inflammation, was investigated. Results obtained were compared with complement activation by inulin and zymosan. It was shown that complement activation by these metal compounds did not necessarily involve either the classical or the alternative pathways. Some of these compounds were unable to activate complement in the absence of detectable plasminogen. The results obtained indicate a relationship between the ability of these compounds to induce chronic inflammation in the guinea-pig and to activate complement.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500133      PMCID: PMC1457138     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  The allergic origin of zirconium deodorant granulomas.

Authors:  W B SHELLEY; H J HURLEY
Journal:  Br J Dermatol       Date:  1958-03       Impact factor: 9.302

2.  Experimental design for bioassay of a material inducing strong tachyphylactic effect (anaphylatoxin).

Authors:  E M ROCHA SILVA; A M ROTHSCHILD
Journal:  Br J Pharmacol Chemother       Date:  1956-09

3.  Pneumoconiosis from exposure to kaolin dust kaolinosis.

Authors:  K M LYNCH; F A McIVER
Journal:  Am J Pathol       Date:  1954 Nov-Dec       Impact factor: 4.307

4.  The significance of protein binding of contrast media in roentgen diagnosis.

Authors:  E C LASSER; R S FARR; T FUJIMAGARI; W N TRIPP
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1962-02

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors:  H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

7.  Activation of complement by radiographic contrast media: generation of chemotactic and anaphylatoxin activities.

Authors:  G Till; U Rother; D Gemsa
Journal:  Int Arch Allergy Appl Immunol       Date:  1978

8.  Nonimmunologic complement activation in normal human serum induced by radiographic contrast media.

Authors:  W P Kolb; J H Lang; E C Lasser
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

9.  Ultrastructural observations on epithelioid cell granulomas induced by zirconium in the guinea-pig.

Authors:  J L Turk; P Badenoch-Jones; D Parker
Journal:  J Pathol       Date:  1978-01       Impact factor: 7.996

10.  The effects of some aluminium and zirconium compounds on guinea-pig peritoneal macrophages and skin fibroblasts in culture.

Authors:  P Badenoch-Jones; J L Turk; D Parker
Journal:  J Pathol       Date:  1978-01       Impact factor: 7.996

View more
  14 in total

Review 1.  Recent progress in adjuvant discovery for peptide-based subunit vaccines.

Authors:  Fazren Azmi; Abdullah Al Hadi Ahmad Fuaad; Mariusz Skwarczynski; Istvan Toth
Journal:  Hum Vaccin Immunother       Date:  2013-12-03       Impact factor: 3.452

Review 2.  Advances in aluminum hydroxide-based adjuvant research and its mechanism.

Authors:  Peng He; Yening Zou; Zhongyu Hu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Current Prospects in Peptide-Based Subunit Nanovaccines.

Authors:  Prashamsa Koirala; Sahra Bashiri; Istvan Toth; Mariusz Skwarczynski
Journal:  Methods Mol Biol       Date:  2022

4.  Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.

Authors:  Hanfen Li; Stephen B Willingham; Jenny P-Y Ting; Fabio Re
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

5.  The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.

Authors:  Tirth Raj Ghimire
Journal:  Springerplus       Date:  2015-04-16

Review 6.  Controlling timing and location in vaccines.

Authors:  Darrell J Irvine; Aereas Aung; Murillo Silva
Journal:  Adv Drug Deliv Rev       Date:  2020-06-26       Impact factor: 15.470

Review 7.  Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want.

Authors:  Harm HogenEsch; Derek T O'Hagan; Christopher B Fox
Journal:  NPJ Vaccines       Date:  2018-10-10       Impact factor: 7.344

8.  Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity.

Authors:  Amy S McKee; Michael W Munks; Megan K L MacLeod; Courtney J Fleenor; Nico Van Rooijen; John W Kappler; Philippa Marrack
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

9.  Mechanisms of action of adjuvants.

Authors:  Sunita Awate; Lorne A Babiuk; George Mutwiri
Journal:  Front Immunol       Date:  2013-05-16       Impact factor: 7.561

10.  Aluminum hydroxide adjuvant differentially activates the three complement pathways with major involvement of the alternative pathway.

Authors:  Esin Güven; Karen Duus; Inga Laursen; Peter Højrup; Gunnar Houen
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.